Top Markets
#1 Velas Velas +367.75%
#2 Gravity Gravity +48.56%
#3 Galxe Galxe +34.81%
#4 Derive Derive +31.62%
#5 Infinity Ground Infinity Ground +29.43%
#6 Wiki Cat Wiki Cat +23.41%
#7 Audiera Audiera +22.88%
#8 Fetch.ai Fetch.ai +22.43%
#9 Fuzzybear Fuzzybear +21.78%
#10 Wrapped QUIL Wrapped QUIL +21.00%
Coin of the day
Velas Velas
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Peringkat dalam Saham #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Harga Saham
$0.00001
Kapitalisasi Pasar
$50.01K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan MultiCell Technologies, Inc. (MCET)

Kategori

Healthcare
Kapitalisasi Pasar
Pendapatan
lebih banyak
Keuntungan
Riwayat Harga
Rasio P/E
Rasio P/S
Rasio P/B
Margin Operasi
EPS
Pemecahan Saham
Dividen
Hasil Dividen
Saham Beredar
Pendapatan untuk MultiCell Technologies, Inc. (MCET)
Pendapatan pada Aug 2015 TTM: $805.24
Menurut laporan keuangan terbaru dari MultiCell Technologies, Inc., pendapatan saat ini (TTM) adalah $805.24. Pada tahun 2013, perusahaan menghasilkan pendapatan sebesar $49.32 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan MultiCell Technologies, Inc. dari 2013 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $805.24 1,532.68%
2014 $49.32 0.00%
2013 $49.32 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $48.44B 6,015,189,493.19%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.04B 1,495,015,026.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.34B 1,781,204,416.44%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B 1,127,901,460.00%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B 1,949,147,196.44%
AU